COST-EFFECTIVENESS OF THYMOGLOBULINE VS. ATG-FRESENIUS FOR INDUCTION IMMUNOSUPPRESSION IN KIDNEY TRANSPLANTATION IN CHINA

被引：0
|
作者：
Xuan, D. [1 ]
Chen, G. [2 ]
Yao, X. [3 ]
Yin, H. [4 ]
Zhang, L. [5 ]
Xuan, J. [6 ]
Chen, L.
机构：
[1] Univ N Carolina, Gillings Sch Publ Hlth, Durham, NC USA
[2] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
[3] Sanofi, Hlth Econ & Outcome Res, Shanghai, Peoples R China
[4] Shanghai Centennial Sci Ltd, Alpharetta, GA USA
[5] Shanghai Centennial Sci Ltd, Shanghai, Peoples R China
[6] Sun Yat Sen Univ, Guangzhou, Guangdong, Peoples R China
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PUK16
引用
收藏
页码：A308 / A308
页数：1
相关论文
共 50 条
  • [1] The cost-effectiveness of induction immunosuppression in kidney transplantation
    Morton, Rachael L.
    Howard, Kirsten
    Webster, Angela C.
    Wong, Germaine
    Craig, Jonathan C.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (07) : 2258 - 2269
  • [2] Use of ATG-Fresenius as an Induction Agent in Deceased-Donor Kidney Transplantation
    Yilmaz, M.
    Sezer, T. O.
    Kir, O.
    Ozturk, A.
    Hoscoskun, C.
    Toz, H.
    [J]. TRANSPLANTATION PROCEEDINGS, 2017, 49 (03) : 486 - 489
  • [3] Thymoglobulin vs. ATG-Fresenius as Induction Therapy in Kidney Transplantation: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
    Song, Turun
    Yin, Saifu
    Li, Xingxing
    Jiang, Yamei
    Lin, Tao
    [J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [4] COST-EFFECTIVENESS OF ANTIBODY INDUCTION IMMUNOSUPPRESSION IN KIDNEY TRANSPLANTATION
    Morton, R. L.
    Howard, K.
    Webster, A. C.
    Wong, G.
    Craig, Jonathan C.
    [J]. NEPHROLOGY, 2008, 13 : A114 - A114
  • [5] Efficacy and Safety of ATG-Fresenius as an Induction Agent in Living-Donor Kidney Transplantation
    Yilmaz, M.
    Sezer, T. O.
    Gunay, E.
    Solak, I.
    Celtik, A.
    Hoscoskun, C.
    Toz, H.
    [J]. TRANSPLANTATION PROCEEDINGS, 2017, 49 (03) : 481 - 485
  • [6] ATG-fresenius induction and immunosuppression without steroids following renal transplantation: A prospective and randomized study
    Cantarovich, D.
    [J]. TRANSPLANT INTERNATIONAL, 2007, 20 : 141 - 141
  • [7] Single-shot antithyrnocyte globulin (ATG) induction for pancreas/kidney transplantation: ATG-Fresenius versus thymnoglobulin
    Schulz, T
    Papapostolou, G
    Schenker, P
    Kapischke, M
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 1301 - 1304
  • [8] ATG-Fresenius increases the risk of red blood cell transfusion after kidney transplantation
    Sebti, Maria
    Petit-Hoang, Camille
    Chami, Btissam
    Audureau, Etienne
    Cordonnier-Jourdin, Catherine
    Paul, Muriel
    Pourcine, Franck
    Grimbert, Philippe
    Ourghanlian, Clement
    Matignon, Marie
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [9] A randomized clinical trial using ATG Fresenius or ATG Merieux as induction therapy in kidney transplantation
    Norrby, J
    Olausson, M
    [J]. TRANSPLANTATION PROCEEDINGS, 1997, 29 (07) : 3135 - 3136
  • [10] ATG-Fresenius or daclizumab induction therapy in immunologically high risk kidney recipients: A prospective randomized pilot trial
    Kim, Min Jeong
    Tsinalis, Dimitrios
    Franz, Stefan
    Binet, Isabelle
    Guerke, Lorenz
    Mihatsch, Michael J.
    Steiger, Juerg
    Thiel, Gilbert
    Dickenmann, Michael
    [J]. ANNALS OF TRANSPLANTATION, 2008, 13 (04) : 21 - 27
12345